Top 5 Clinical Trials Shaping Medicine in 2025
From precision oncology to gene editing, these standout trials could redefine how to diagnose and treat rare diseases and cancer
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
From precision oncology to gene editing, these standout trials could redefine how to diagnose and treat rare diseases and cancer
Research reveals that diagnostic error in the US may cause up to 800,000 serious outcomes annually.
The agency recently sent its own proposed LDTs regulation rule to the White House Office of Information and Regulatory Affairs for review.
Owlstone Medical CEO Billy Boyle discusses the latest developments in breath biopsy and issues related to its wider clinical adoption.
A new five-metabolite blood test designed by algorithm could simplify and speed up this challenging diagnosis.
Protein levels in the vitreous humor may have the potential to support the diagnosis and staging of neurodegenerative diseases.
A new assay uses AI-optimized enzymes to simplify and increase the accuracy of rapid pathogen detection.
Accessible screening tests and inclusive management strategies may limit the global cervical cancer incidence rate.
New program aims to provide greater transparency on the recommended performance characteristics of such tests.
Multiorgan analysis of biobank data elucidates heart–brain links that could enhance disease prevention and detection.
The agency recently announced it will decide in December whether to grant clearance for a CRISPR therapy for treating sickle cell disease.